At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 150 enrolled
Drug / intervention
IDP-122 Vehicle Lotion +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion (0.01% Halobetasol Propionate) to Ultravate® (Halobetasol Propionate) Cream, in the Treatment of Plaque Psoriasis
In Brief
A Phase 2 clinical trial evaluating IDP-122 Vehicle Lotion, IDP-122 Vehicle Cream, and 2 other interventions for Psoriasis. Completed, enrolled 150 participants across 13 sites.
Detailed Summary
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartJun 2016
Primary CompletionDec 2016
Study CompletionJan 2017
TodayJul 2026
First PostedMay 27, 2016
Enrollment StartJun 1, 2016
Primary CompletionDec 2, 2016
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.1 years ago
Interventions
IDP-122 Vehicle Lotiondrug
Vehicle
IDP-122 Vehicle Creamdrug
Vehicle
IDP-122 Lotiondrug
Lotion
Ultravate Creamdrug
Cream